Neurodegenerative Disease Diagnostic Program
Neurodegenerative Diseases (e.g., Alzheimer's, Parkinson's)
Pre-clinical/Assay DevelopmentActive
Key Facts
Indication
Neurodegenerative Diseases (e.g., Alzheimer's, Parkinson's)
Phase
Pre-clinical/Assay Development
Status
Active
Company
About ESP Diagnostics
ESP Diagnostics is a private, pre-revenue company founded in 2010, specializing in the diagnostics sector with a sharp focus on neurodegenerative diseases. Its core business involves developing and manufacturing diagnostic tests and reagents, positioning it to capitalize on the growing demand for early and accurate detection tools in neurology. The company appears to be in a pre-commercial or early development stage, as indicated by its 'website pending' status and limited public information. Its success will hinge on advancing its technology platform through clinical validation and securing commercial partnerships.
View full company profileTherapeutic Areas
Other Neurodegenerative Diseases (e.g., Alzheimer's, Parkinson's) Drugs
| Drug | Company | Phase |
|---|---|---|
| TCAP Platform | Protagenic Therapeutics | Preclinical |
| Ocular Tracer Platform | Amydis Diagnostics | Phase 1 |
| NeurOdys Therapeutics (Portfolio Company) | Expert Systems | Pre-clinical |